Summary
Introduction
The meninges, spinal nerve roots and cranial nerves are most commonly involved in LNB. Chronic CNS involvement of LNB may mimic diseases such as neurosyphilis, meningoencephalitis of viral, fungal or mycobacterial origin, multiple sclerosis, brain tumor, autoimmune disease, stroke or Alzheimer's disease.
Despite a rapid increase in the number of patients with LNB its neuropathological aspects are poorly understood (Garcia-Monco and Benach, 1995) . In principle, the brain lesions can be caused either directly by the spirochaete or indirectly via biologically active substances secreted by host cells on stimulation with the spirochaete. Borrelia burgdorferi is able to adhere to and penetrate through the endothelium of CNS blood vessels and then adhere to the glial cells (Garcia-Monco et ai, 1989; Comstock and Thomas, 1989;  © Oxford University Press 1996 Szczepanski et al., 1990) . This invasion can already occur at early stages of the infection, even without signs of inflammation in the CSF (Garcia-Monco et al., 1990; Luft et al., 1992) . After invasion of the CNS, the spirochaete may cause direct damage to oligodendroglial cells, which may lead to demyelination (Baig et al., 1991) . However, there is increasing evidence that inflammatory changes in CNS blood vessels, such as diffuse or focal vasculitis or cerebrovascular injury, may be an important factor in the development of the CNS lesions and dysfunction in LNB (Midgard and Hofstad, 1987; Uldry et ai, 1987; Weder et al., 1987; Wokke et al., 1987) . It is conceivable that Lyme borreliosis may also cause vascular damage in the CNS, because it is known to cause vasculitis and perivascular inflammation in several other organs outside the CNS (Johnston et ai, 1985; Camponovo and Meier, 1986; Duray, 1989a, b; Meurers et al., 1990; Moody et al, 1990a; Olson and Esterly, 1990; Smith et al., 1991; Karma et al, 1995) . The factors involved in the development of the vascular changes in LNB are not known. It is evident that the spirochaete occurs in very low numbers especially in the CNS, since its presence in brain tissue has been a rare finding (MacDonald and Miranda, 1987; Weber et al., 1988; Pachner et al., 1989; Kuntzer et al., 1991; Millner et al., 1991; Miklossy et al., 1994) , suggesting that CNS lesions are also caused by inflammatory mediators and not only by the direct action of the spirochaete itself. One recent study showed that B. burgdorferi is capable of direct activation of vascular endothelium promoting recruitment of leucocytes to perivascular tissues (Sellati et al, 1995) .
Modern imaging techniques, such as CT and MRI, are used successfully for the detection of vascular lesions in the CNS of LNB patients (Uldry et al, 1987; Kohler et al., 1988; Belman et al, 1992) , and together with sensitive gene amplification methods, such as polymerase chain reaction (PCR), they have improved the possibilities of studying the role of B. burgdorferi in the development of vasculitic lesions.
We describe three patients with CNS lesions shown by MRI and neurological symptoms. In two of the patients, B. burgdorferi DNA was detected by PCR in specimens from inflammatory CNS lesions; it was cultivated from the CSF of one of these two. In the child with hemiparesis and vasculitis in the brain, borrelia PCR yielded positive results with CSF.
Patients and methods

Patients
Two patients living in an area where Lyme borreliosis is endemic were examined at the Turku University Central Hospital. One patient, who had briefly visited an endemic area, was examined at the Oulu University Central Hospital.
Magnetic resonance imaging
All patients were examined using a high-field magnet (1.5 Magnetom, Siemens) with T 2 and T, sequences (TR 2500, TE 90 and TR 600, TE 15). Gadolinium enhancement was also used. Axial, coronal, and sagittal planes were imaged.
Assessment of borrelia antibodies
The IgM and IgG antibodies against sonicated B. burgdorferi were measured by an in-house ELISA using B. burgdorferi sensu stricto (B31, ATCC 35210) as the antigen (Viljanen and Punnonen, 1989) . All steps of the ELISA were carried out automatically with an Auto-EIA II instrument (Labsystems, Helsinki, Finland) . Serum samples were tested at a dilution of 1:100. The results were expressed as relative ELISA units. Seropositivity was determined by comparing antibody results from test serum samples with those of 110 healthy controls.
The cut-off value for weakly positive results was the mean + (2XSD) of the controls. The IgM and IgG antibodies against flagellin were measured using a commercial ELISA test (Lyme Borreliosis ELISA Kit, 2nd generation; DAKO A/S, Glostrup, Denmark). The CSF samples were tested at a dilution of 1:10. The CSF IgM and IgG antibodies against sonicated B. burgdorferi were measured using the in-house ELISA (EIU units > 10 were considered positive) and against flagellin by a commercial ELISA (DAKO).
Culture of B. burgdorferi
The specimens (biopsy, CSF or blood) were inoculated into tubes containing BSK-II medium and incubated at 30°C. The tubes were examined macroscopically twice weekly and passaged once weekly for at least two months. Dark-field microscopy was carried out if the colour of the culture medium indicated growth. The final identification of cultured spirochaetes was based on PCR.
Extraction of DNA for the PCR
A 1 ml sample (i.e. minced biopsy specimen, plasma, serum or CSF) was centrifuged (Eppendorf Microfuge, 13000 r.p.m., 10 min), 800 u.1 of the supernatant was removed, and the remaining 200 p.1 was mixed with 300 (il of sodium dodecyl sulphate (SDS) solution (0.1 M NaOH, 2 M NaCl and 0.5% ). After incubation at 80°C for 15 min, 200 |il of 0.1 M Tris-HC1 (pH 8) was added. After the SDS treatments, DNA was extracted with phenol-chloroform, precipitated with ethanol and finally dissolved in Tris-EDTA buffer (Hance etal, 1989) .
Polymerase chain reaction
A 5 u.1 volume of extracted DNA was added into the reaction tube. The specific targets chosen for the PCRs were DNA fragments from the flagellin gene sequence of B. burgdorferi. The PCR from all specimens obtained from Patient 1, and from the brain tissue specimens of Patient 2, was run in two steps, first with external primers prB31/41 -4 and prB31/41-5, resulting in a 730-bp PCR product (Wallich et al, 1990) and then with nested primers WK1 and WK2, resulting in a 290-bp fragment (Kriiger and Pulz, 1991) . Finally, the PCR from specimens obtained from Patient 3, and the plasma of Patient 2 was run as described earlier with primers WK1 and FL7, resulting in a 497-bp PCR product (Kriiger and Pulz, 1991; Picken, 1992; He et al, 1994) . Each PCR run included a positive control containing DNA extracted from a reference strain (B31) of B. burgdorferi sensu stricto (ATCC 35210). Control brain tissue samples were included in the PCR runs in a blinded manner and with negative results. Every sixth tube of each run was used as a negative control subjected to all above sample treatments. The negative controls remained negative in each run. One hundred blood donors living in the Turku area provided control samples for the PCR assay with primers WK1 and FL7: one of their samples was positive. Similar studies on blood donors was not done for the other above mentioned PCR assays with different primer pairs. The sensitivity of the PCR with WK1 and FL7 primers (He et ai, 1994) was found to between 10 and 100 B. burgdorferi cells per reaction. The sensitivities of the other PCR modifications were at the same level as that with WK1 and FL7 primers. All PCRs used were found highly specific for B. burgdorferi s.l. Other Borrelia species (B. hermsii, B. parkeri and B. turicatae) and treponemes (Treponema denticola, T. pectinovorum, T. socranskii and T. vincentii) gave negative results.
Neuropathology
Surgical samples were fixed in 4% phosphate buffered formaldehyde and routinely processed into paraffin sections. Brains from autopsies were also fixed in the same fixative. During cutting of the brains, samples from areas judged as abnormal on brain imaging and from areas with macroscopic pathological features were collected and processed into paraffin sections. The specimens were stained using haematoxylin and eosin (H and E), and Luxol Fast BlueCresyl Violet stains. Inflammatory cells were demonstrated immunohistochemically using mouse monoclonal antibody to CD 45 and leucocyte common antigen (Dakopatts A/S, Glostrup, Denmark). Bound primary antibodies were detected applying an appropriate Vectastain (Vector Laboratories, Burlingame, Calif., USA) avidin-biotin-peroxidase detection kit with diaminobenzidine as chromogen.
Results
In two cases (Patients 1 and 2), the brain tissue specimen from areas with vasculitic lesions contained DNA of B. burgdorferi as evidenced by PCR amplification (Table 1) . In one of them, culture as well as PCR of the CSF showed B. burgdorferi (Patient 1). In addition, the plasma of both of the patients (Patients 1 and 2) contained DNA of B. burgdorferi. In the remaining one patient, DNA of B. burgdorferi was amplified in the CSF (Patient 3). In all patients, a positive PCR result was obtained from more than one specimen taken and analysed at different times (Table  1) . Two of the patients had antibodies against B. burgdorferi in the serum but none of the patients had them in the CSF. Circulating immune complexes were found in both two patients studied (Table 1) .
In one patient (Patient 1), MRI of the brain showed large periventricular lesions in white matter and the disease had a fatal outcome. MRI findings in two patients (Patients 2 and 3) suggested malignancy before the histopathological studies were carried out. One of them was a child with sudden hemiparesis. Another was a 40-year-old man who presented with epileptic seizures; his MRI showed multifocal lesions, which disappeared after repeated antibiotic therapy.
Perivascular or vasculitic lymphocytic inflammation in the clinical or autopsy brain biopsy specimens was detected in all three patients. Large areas of demyelination in periventricular white matter were detected in one patient (Patient 1). Detailed neuropathological descriptions are included in the following case reports.
Patient 1
The patient was a 51-year-old woman with a history of progressive lymphedema of the left lower limb since 1954. She had suffered from erysipelas in the left lower leg and erythema nodosum in both legs, and had also had recurrent fever episodes several times a year. Lung fibrosis, heart insufficiency and chest pain atypical of coronary heart disease developed at the age of 30-35 years. She had received longterm corticosteroids and several courses of antimicrobial drugs.
In 1985, the patient had a 3 week period of fever and facial redness suggestive of lupoid erythema. Despite corticosteroid treatment, a spiking fever persisted. At hospital, no infection focus was found. Antimalarial drugs combined with methylprednisolone were given for two years, but episodes of mild fever reappeared. Antinuclear antibodies and antibodies against extractable nuclear antigens were repeatedly negative. Anti-DNA-antibodies were found slightly positive.
After September 1988, she was hospitalized several times for prolonged vomiting, fatigue, fever, dizziness and progressive walking difficulties with ataxia and short gait. In addition, impairment of memory, taste, and hearing occurred. In February 1989, the erythrocyte sedimentation rate (ESR) was 125 mm h~', serum C-reactive protein 83 mg I" 1 (normal <10 mg I" 1 ), and leucocytes 9.2X10 9 I" 1 with 96% granulocytes. Sinus X-ray showed sinusitis, and the brain CT showed an empty sella. Despite treatment with methylprednisolone and i.v. erythromycin, the ESR and Creactive protein remained elevated. At CSF examinations (February 1989 and January 1991) , leucocyte counts and protein concentrations were normal, as was the IgG/albumin ratio, but one or two subfractions were observed with protein electrophoresis. In January 1991, MRI of the brain showed enlarged ventricles, cortical atrophy, and marked degenerative changes in the peri ventricular areas (Fig. 1A) . Total serum immunoglobulins were normal, but immune electrophoresis showed an M-component (IgG lambda). Circulating immune complexes also occurred. Rheumatoid factor, antinuclear antibodies, anticardiolipin, TPHA (Treponema pallidum haemagglutination test), antiphospholipid antibodies, and antibodies against 6. burgdorfeh were negative in the serum. Leucocytes were 3.5X10 9 1"' with an excess of band forms.
In August 1991, CSF examination showed no inflammatory cells, a slightly elevated protein concentration of 762 mg I" 1 , and no antibodies against B. burgdorferi. Culture of CSF in BSK-II medium showed very slow growth of spirochaetes during 3 months. Using monoclonal antibodies, immunofluorescence and PCR, the spirochaete was identified as B. burgdorferi s.l.
In December 1991, antimicrobial treatment with ceftriaxone (2 g i.v. daily) was instituted. The patient improved slightly, and therapy was continued after 3 weeks with oral amoxicillin (500 mg every 8 h) and oral probenecid (500 mg every 8 h). After 1 week on amoxicillin, the patient developed urticaria. Oral doxycycline (100 mg every 12 h) was substituted and continued until July 1992. During this treatment, the walking difficulties and fever episodes recurred. All cultures for fungi and common bacteria were negative. In January 1992, brain MRI showed slight progression of the periventricular lesions from the image obtained 1 year earlier. In March and July 1992, subdural haemorrhages of unknown origin were evacuated.
On August 7, 1992, plasma and bone marrow specimens were positive for B. burgdorfeh PCR. Treatment with ceftriaxone (2 g i.v. daily) was reinstituted, the patient reacting with high fever. Empirical antifungal therapy with amphotericin B was also started. These treatments were continued until the patient died on September 12, 1992.
At autopsy, the pathological changes were slighter than expected. The spleen was slightly enlarged. Chronic liver stasis and mild pulmonary oedema were detected. No signs of fungal infection were seen. Neuropathological examination showed a chronic left-sided subdural haematoma. Its structure was compatible with the haemorrhages occurring 6 and 2 months before death. An increased number of plasma cells were present within the organizing connective tissue of the haematoma. In subcortical and periventricular white matter, diffuse demyelination with mild perivascular inflammation was seen ( Fig. IB and C) . In one of the six analysed brain tissue specimens, B. burgdorferi DNA was detected by the PCR.
Patient 2
This 40-year-old man had previously been healthy, apart from reactivation of a genital herpes infection some weeks before. He recalled no tick bites or erythema migrans. On December 26, 1992, he had a generalized seizure and was admitted to the hospital. Another seizure occurred on the day of admission. Brain CT was normal. On admission, CSF examination showed an unremarkable increase of protein level (688 mg I" 1 ) with no inflammatory cells. The PCR assays for herpes simplex virus (HSV) and antibodies against viruses were negative in the CSF. Serum IgM antibodies against B. burgdorferi were found at a low level and IgG antibodies against Chlamydia pneumoniae were moderately elevated. Serum C-reactive protein was 50 mg 1"', lactic dehydrogenase 927 U I" 1 (normal value < 440 U I" 1 ) and bilirubin 36 |J.mol 1~' (normal value <20 |imol l"'l), but the changes were transient. Other laboratory tests were normal including serum hepatitis B surface antigen, antibodies against HIV and herpes viruses. The EEG showed an irritative focus in the left hemisphere.
On December 30, MRI of the brain showed three small frontal lesions at the bottom of the left frontal lobe near the meninges. The imaging of these lesions was enhanced using contrast medium (Fig. 3A) . In the right pleural cavity, a chest X-ray examination showed fluid, which disappeared in 2 weeks. The CT showed a central cystic lesion in the left kidney, but no abnormal findings were obtained in the mediastinum, lungs, or pleural cavities. On December 31, a CSF examination showed 4X10 6 1"' lymphocytes, but protein (373 mg I" 1 ), and angiotensin convertase enzyme and lysozyme concentrations were normal. The CSF antibodies against herpesviruses, B. burgdorferi, and Treponema pallidum were negative as was antigen detection for HSV and PCR for B. burgdorferi. The PCR for HSV was positive with this specimen. Culture for viruses and mycobacteria remained negative.
On January 8, 1993, a frontally located brain lesion was resected for suspected malignancy. Histopathological studies p. . : showed lymphocytes in the walls of leptomeningeal and small penetrating arteries as well as in the perivascular space of the latter (Fig. 2B) . The adjacent cortex was slightly oedematous with very mild astrocytic gliosis. A PCR analysis of three separate brain specimens detected DNA of B. burgdorferi. The IgM (but not IgG) antibodies against B. burgdorferi were positive only in the first pretreatment serum sample but negative thereafter. The circulating immune complexes and complement activation products were positive. The IgG antibodies against C. pneumoniae were elevated at a constant level, but IgM antibodies remained negative, indicating that the IgG antibodies were of earlier origin. A neuropsychological investigation showed memory impairment affecting verbal function and slightly impaired fluency of verbal expression. Anticonvulsive therapy with carpamazepine was started. Table 2 shows changes in the antimicrobial treatment schedule and the development of the brain lesions appearing on MRI. During the antibiotic treatment, MRI of the brain showed new lesions: one enhancing lesion (2 cm in diameter), suggestive of focal vasculitis, located medially from the. postoperative area, and later, enhancing lesions at the bottom of the right frontal lobe and a frontal lobe sulcus (Fig. 3A  and B) . However, the initial lesion at the bottom of the left frontal lobe behind the orbita was now markedly smaller than at previous examinations. Later images showed that the A close group of three frontal lesions (Fig. 2) . Operative resection.
A new enhancing lesion medially from the postoperative area.
Three new lesions distant from the primary lesions (Fig. 3) . (Fig. 3) The focus seen on previous MRI disappeared. A new focus in a frontal sulcus and a large periventricular lesion (Fig. 3) . End of antibiotic therapy. first lesion was constantly reducing in size, and five months after onset of antibiotic therapy all the new foci of the putative vasculitic process had also disappeared. The antibiotic therapy was discontinued on July 5, 1993.
The patient was asymptomatic at the end of therapy. Whole body bone scanning was carried out in June 1993 because of a history of pain in the thoracic spine some months earlier.
Slightly increased uptake of isotope in the thoracic spine was seen, but the finding was considered unspecific. The EEG after sleep deprivation was normal in July 1993.
Five months after the end of antibiotic therapy, brain MRI showed a new focus located adjacent to the third ventricle ( Fig. 3A and B) . Oral antibiotic treatment was started (the patient was asymptomatic; jeeTable 2). The next MRI showed that the treatment had probably had a beneficial effect on the former lesions, but again, a new focus in a frontal sulcus and a relatively large pathological area in periventricular white matter were detected (Fig. 3B) . On May 17, 1994, DNA of B. burgdorferi was detected by PCR in the patient's plasma specimen (Table 2 ). Intravenous antibiotic therapy was reinstituted and continued for 100 days. Thereafter, on MRI studies of the brain, all lesions and periventricular enhancement have disappeared, and no new lesions have developed to date ( Table 2 ). The antiepileptic therapy has been discontinued, and no new seizures have occurred.
Patient 3
In the summer of 1993, this previously healthy 11-year-old girl had visited an area in Southern Finland where Lyme borreliosis is endemic. In September 1993, occasional episodes of hyperactivity followed by headache were observed by her family. On October 1, she developed paresis of the right lower limb. On October 7, she was admitted to a local hospital and 1 week later to the Oulu University Central Hospital. Standing on the right leg alone was difficult, and walking was slightly impaired.
On October 13, CT of the brain showed a periventricular low density enhancing lesion, 10X6 mm 2 in diameter, and located in left parietal lobe white matter. The lesion was suggestive of a neoplasm. On the next day, using MRI, the dimensions of the enhancing lesion were found to be Table 3 .), marked with T in frontal schematic view summarized from three close MR images (A). The initial lesions (not shown) were now markedly smaller than in previous images. In July 1993, at the end of antibiotic treatment, the MRI showed only postoperative changes in the left frontal lobe while all other lesions were no longer detectable. In December 1993 the MRI showed a new focus (marked with '2') adjacent to the third ventricle (A and B). Again, the next MRI in April 1994 showed a new focus (marked with '3') in the frontal sulcus and a large lesion (marked with '3') in periventricular white matter (B). In October 1994 the MRI demonstrated the disappearance of all lesions after vigorous antibiotic treatment (see Table 2 ).
40X20x8 mm 3 and the surrounding oedematous area was 20-30 mm thick (Fig. 4A) . The EMG was normal. Abdominal ultrasonography showed mild splenomegaly.
On October 22, a craniotomy was carried out. In the area of the enhancing lesion, shown by MRI, elastic and stretchy tissue with abnormal white colour was detected. On histological examination, focal necrotic areas were found, surrounded by foamy macrophages, reactive astrocytes and oedema. (Fig. 4B ). An increased number of small vessels with thickened walls and prominent endothelial cells were also seen. Lymphocytes occurred in the walls of some vessels. Haemoglobin, ESR, and serum C-reactive protein values were normal. Serum total immunoglobulins were normal, except for a slightly increased value of IgM at 1.94 g 1"' (normal value 0.35-1.63 g I" 1 ). Serum rheumatoid factor, antinuclear antibodies, extractable nuclear antigens, anti-DNA-and anti-phospholipid antibodies were negative, and so were antibodies against several viruses. On November 4, lumbar puncture was carried out. The CSF specimen gave a negative virus culture and HSV PCR but B. burgdorferi PCR was positive with two separate CSF specimens (detected at two separate runs).
December 21, 1993, antibiotic therapy with ceftriaxone (2 g i.v. daily) was started for 4 weeks followed by therapy with oral amoxicillin (500 mg every 8 h) combined with oral probenecid (500 mg every 8 h). On February 1, the antibiotic therapy was stopped because of bloody diarrhoea. Culture and toxin detection for Clostridium difficile were negative. The diarrhoea was cured with oral metronidazole.
On February 1, 1994, MRI of the brain showed reduction of abnormal tissue around the operative area. At this time, no enhancement was seen in the walls of the cavity. At a follow-up of 1 year, recovery was observed with only a slight abnormality in walking. No new symptoms had developed.
Discussion
In this study, the evidence for the presence of B. burgdorferi was mainly based on positive PCR results. However, in one patient the spirochaete was also cultured from the CSF. The PCR detected DNA of B. burgdorferi directly in the brain lesions of two patients, and in the CSF, plasma or bone marrow of all three patients. In two patients, a positive PCR result was obtained from more than one type of specimen. Based on the results of control specimens and on the rigorous contamination control we consider our PCR results reliable. Since two of the patients had no previous antibiotic treatment before the first PCR-positive samples were obtained, it is highly probable that the PCR results indicate an ongoing infection. The CSF sample obtained from the third patient with a history of several previous antibiotic courses for other reasons was also culture-positive. The causative role of borrelial infection was supported by constriction or disappearance of the lesions in two patients after antimicrobial therapy directed against B. burgdorferi.
Both clinical and experimental studies have shown that B. burgdorferi can rapidly and effectively penetrate the CNS (Garcia-Monco et al, 1990; Luft et al., 1992) . Interaction with the intraluminal endomelial surface by the spirochaete, directly or via systemic cytokines, was necessary for the increase of the permeability of the blood-brain barrier (BBB). The dissemination of B. burgdorferi to various organs depends on its ability to adhere to and penetrate the endothelium, and the BBB as well (Garcia-Monco et al., 1990) . In an in vitro model, B. burgdorferi was shown to adhere to the endothelial surface or to an exposed subendothelial basement membrane and migrate between endothelial cells, either at their junctions or in an area with endothelial damage (Comstock and Thomas, 1989; Szczepanski et al., 1990) . Recent findings indicate that B. burgdorferi can acquire proteolytically active host components. This mechanism could facilitate the dissemination and localization of spirochaetes to sites of vascular injury (Klempner et al., 1995) . The affinity of the organism for astrocytes, the nearest neighbours of brain capillaries, could facilitate its access to the nervous system . The breakdown of the BBB noted after i.v. inoculation of B. burgdorferi (GarciaMonco et al., 1990) may be due to either generalized or focal production of inflammation mediators after adhering of spirochaetes to the endothelium. Focal vasculitis may then be developed by activation of endothelial cells and further release of inflammation mediators. Involvement of the CNS is associated with scattered peri vascular mononuclear cell infiltrates in the cerebral cortex, mainly consisting of T-helper cells (Meurers et al., 1990) . The infiltrates are sometimes accompanied by mild, spongiform changes, a focal increase in microglial cells, and a modest infiltration of lymphocytes and plasma cells in the leptomeninges (Duray, 1989a) .
Our observations support results from both experimental and clinical investigations suggesting that the number of B. burgdorferi spirochaetes in the CNS is very low. The spirochaete could be cultivated from the CSF of only one of our patients. To date, almost all attempts to isolate B. burgdorferi from human brain tissue have failed. Culture of B. burgdorferi-Yike organisms from brain tissue affected by Alzheimer's disease has been reported twice (MacDonald and Miranda, 1987; Miklossy et al., 1994) . A few other reports have been published showing the agent in biopsy or autopsy specimens. In one patient with subacute encephalitis, a brain biopsy specimen showed spirochaetes morphologically compatible with B. burgdorferi and microgliosis without inflammatory infiltrate (Pachner et al.. 1989) . In a newborn whose mother had suffered from Lyme borreliosis in early pregnancy and who died during the first day after birth, B. burgdorferi could be demonstrated by staining and immunocytochemistry in the brain and liver (Weber et al., 1988) . One child with a history of severe arthritis for several months died during a protracted seizure which was her first neurological manifestation of the disease; histological studies of brain tissue showed general vasculitis, and B. burgdorferi was demonstrated by silver staining (Millner etai, 1991) . Brain involvement during experimental infection with B. burgdorferi has been reported in several animal models (Johnson et al., 1984; Burgdorfer and Gage, 1987; Barthold et al., 1988; Garcia-Monco et al., 1990; Moody etai, \990b; Pachner and Itano, 1990; Barthold et al. 1992) , but even in these experiments the presence of borreliae in the brain or CSF has often been short-lived.
The pathogenesis of CNS manifestations in Lyme borreliosis is inadequately known. Our observations support earlier reports suggesting that vasculitis may be one of the primary pathophysiological mechanisms in neuroborreliosis (Camponovo and Meier, 1986; Midgard and Hofstad, 1987; Kohler et al., 1988; Meier and Grehl, 1988; Mokry et al, 1990; Meurers et al., 1990) . This is only logical, because B. burgdorferi infection frequently causes perivascular inflammation or vasculitis (e.g. retinal vasculitis) in affected organs other than the CNS (Duray. 1989a, b; Olson and Esterly, 1990; Smith et al, 1991; Karma et al, 1995) . In general, micro-organisms causing retinal vasculitis have been found to be much the same as those causing cerebral vasculitides (Somer and Finegold, 1995) . In the peripheral nervous system, inflammatory vascular changes or vasculitis seem to cause axonal degeneration in Lyme borreliosis (Camponovo and Meier, 1986; Meurers et al, 1990) . Studies on experimental borrelia infections have also shown prominent lymphoplasmacellular infiltration in the microvasculature, endarteritis obliterans, and spirochaetes in and around blood vessels of synovial and myocardial tissues (Johnston et al, 1985; Moody et al, 1990a) . Vasculitis also is a predominant finding in T. pallidum infection, another spirochetal disease with CNS invasion (Kohler et al., 1988; Coyle and Dattwyler, 1990) . Syphilitic endarteritis may cause multiple small infarctions in the CNS, or involve the vasa vasorum of large or medium-sized vessels, and lead to aneurysms or ischaemic infarction months or years after onset of infection.
Our study supports a sporadic causative role for B. burgdorferi infection in stroke-like diseases or vasculitis in agreement with previous studies (Midgard and Hofstad, 1987; Uldry et al., 1987; Veenendaal-Hillbers et al., 1988; May and Jabbari, 1990; Millner et al., 1991; Hammers-Berggren et al., 1993) . This is also in agreement with the recent finding that patients with chronic Lyme disease encephalopathy have multifocally reduced blood perfusion to the cerebral hemispheres, particularly in white matter, and that these patients show objective improvement in brain perfusion after antibiotic treatment (Steere et al, 1994) .
The brain autopsy specimens of Patient 1 showed extensive demyelination in periventricular areas, and B. burgdorferi was cultivated from the CSF. This finding, combined with the long history of her disease (decades), indicates that B. burgdorferi may occasionally cause pronounced demyelination, possibly via damage to microvasculature, similar to that seen in neurosyphilis. Several studies have found an association between demyelinating disease and B. burgdorferi infection (Reik et al., 1985; Kohler et al., 1988; Pachner et al., 1989; Clavelou et al., 1993) , although in multiple sclerosis B. burgdorferi infection rarely seems to be the trigger (Coyle, 1989; Baig et al., 1991; Coyle et al. 1993) . Direct damage to oligodendroglial cells may cause demyelination because B. burgdorferi very actively binds to them (Baig et al., 1991) . This binding may partly explain the long-term persistence of B. burgdorferi in the CNS and explain why the spirochaete is seldom isolated from the CSF (Garcia-Monco et al., 1989; Pachner and Delaney, 1993) . Galactocerebroside, a component of myelin, and other glycosphingolipids are possible binding structures for B. burgdorferi and other related spirochaetes causing disease in the central and peripheral nervous systems Backenson et al., 1995) . Autoimmune reactions, triggered by B. burgdorferi infection, may also cause demyelination. B-cells capable of responding to myelin basic protein have been a common finding in the CSF of patients with LNB (Baig et al., 1991) . Because nervous tissue is considered an immunologically privileged site, autoreactive B-cells, and autoantibodies as their products, may arise as a result of host response to neuronal antigens exposed by tissue damage. Another explanation to autoreactivity could be molecular mimicry and cross-reactions between neuronal autoantigens and antigens of B. burgdorferi (Sigal and Tatum, 1988; Sigal, 1993) . Experimental studies on SCID (severe combined immuno-deficient) mice, however, show that at least arthritogenesis is not necessarily dependent on an intact immune system, since chronic arthritis is inducible in these mice .
Brain lesions in Patient 2 developed in previously intact areas during or after treatment, the last one of them 16 months after onset of prolonged antibiotic therapy. Several reports have been published on the occurrence of new foci and paradoxical enlargement of CNS lesions during the treatment of mycobacterial CNS infections (Afghani and Lieberman, 1994) . The direct effects of mycobacterial products or the host's immunological reactions elicited by microbial components have been offered as the most likely explanation for the appearance of new foci in mycobacterial infections (Afghani and Lieberman, 1994) . Similar mechanisms could explain the development of new lesions during therapy in Patient 2. However, DNA of B. burgdorferi in the plasma of the patient over 16 months after the onset of first antibiotic treatment suggests the presence of ongoing infection. The route of entry to the new sites could have been the vascular wall after occurrence of subclinical spirochaetemia. Another explanation for the onset of new lesions is that the spirochaetes were already at the site of lesions before the antibiotic treatment. Because of metabolic inactivity, they were not affected by the antibiotics. After a latent period, the uneradicated spirochaetes could have activated and caused changes visible on brain MRI. The disappearence of all lesions after repeated therapy further supports the theory that the lesions were directly related to B. burgdorferi infection. Our experience with this patient suggests that, in rare cases, extended or repeated antibiotic treatments may be necessary to eradicate the spirochaete from sites where it has aquired a latent state.
The diagnosis of LNB has usually been based on nonspecific findings, serological testing and other indirect methods. Stereotactic biopsy or a surgical operation are necessary for direct demonstration of an etiological agent in vasculitis or brain lesions. However, evidence for the presence of B. burgdorferi could be obtained by culture or PCR of the CSF or plasma specimens in all three of our patients. This is consistent with the earlier finding that small numbers of spirochaetes or their structures occasionally circulate in the blood not only in early infection but also during the later stages of Lyme borreliosis (Viljanen et al., 1992; Nadelman et al., 1994; Oksi et al., 1994 and 1995a, b; Oksi, 1995) . Thus, MRI findings compatible with vasculitis associated with a positive PCR result from the CSF or plasma, even without direct demonstration of the spirochaete in the brain lesions, might be an indication for antimicrobial treatment directed against B. burgdorferi.
Our patients had no borrelial antibodies in their CSF. This result is in contrast with most published studies on European neuroborreliosis patients, in whom intrathecal antibody production has usually been detected. Indeed, intrathecal antibody production has been one of the criteria for the diagnosis of neuroborreliosis (Steere et al. 1990; Baig el al., 1991; Lebech, 1991, 1992) . By contrast, American patients with LNB often show no intrathecally produced antibody (Steere et al., 1990; Kuntzer et al., 1991; Luft et al., 1992) . It is not known whether the differences reported between American and European LNB patients are due to patient selection or some other factor (Steere et al, 1990) . However, our results indicate that the differences between European LNB and its North-American counterpart may not be as great as has been suggested. Three plausible explanations for the lack of intrathecal antibody production in LNB may be suggested. First, the CNS can be considered an immunoprivileged site where the spirochaete can lie latent out of reach of the host immune system (Guy and Turner, 1989; Pfister et al, 1989; Halperin et al., 1991) . Second, studies with T cell clones suggest that B. burgdorferi may shift the immune response of the host towards cell-mediated immunity at the expense of antibody production (Yssel et al., 1991) . This is advantageous from the spirochaete's point of view, because antibodies are obviously the major factor in the host defense against B. burgdorferi infection (Fikrig et al., 1992) . We have also obtained evidence that B. burgdorferi infection can cause suppression of Th2 cells and activation of Thl cells in patients with late Lyme borreliosis (Oksi et al., 1996) . Third, immune complex formation and binding of antibodies to complexes may be a mechanism underlying the negative results of routine antibody assays (Schutzer et al., 1990) .
Hemiparesis (Uldry et al., 1987; Veenendaal-Hilbers et al, 1988; May and Jabbari, 1990) , which was the main manifestation in one of our patients, and epilepsy (Millner et al, 1991; Mourin et al, 1993) , the dominating symptom of another" patient, have also been reported to be associated with LNB. The almost complete recovery of our patient from the hemiparesis, and the complete disappearance of brain foci and recovery from the epilepsy in another patient after antimicrobial treatment may suggest infectious etiology. We recommend exclusion of Lyme borreliosis as a trigger of disease in selected patients with demyelinating disease, hemiparesis, or epilepsy.
We conclude that cerebral lymphocytic vasculitis and multifocal encephalitis may be associated with B. burgdorferi infection. The presence of B. burgdorferi DNA in tissue samples from areas with inflammatory changes indicates that direct invasion of B. burgdorferi may be the pathogenetic mechanism for focal encephalitis in Lyme neuroborreliosis.
